Specialty Pharmacy

A combination of vemurafenib (Zelboraf) and experimental drug cobimetinib significantly reduces the development of secondary skin cancer.

Adding panobinostat to a combination treatment of bortezomib and dexamethasone in heavily pretreated patients boosts progression-free survival, but overall survival data are not yet mature.

In a recent phase III trial, a 3-medication regimen showed efficacy in reducing treatment-related nausea and vomiting in patients with multiple myeloma undergoing induction therapy before autologous stem cell transplant.

Obama calls for international response to prevent "humanitarian catastrophe."

A combination of Lactobacillus plantarum and a modified inulin derivative reduced expression of T-cells in mammary cancers induced in rats.

A recent metaanalysis suggests that prediabetes increases the risk of developing certain cancers, particularly in tissues located near the gastrointestinal tract.

RX-3117 maintains anti-tumor activity in cancer cell lines that are resistant to gemcitabine.

Thomas Cohn, chief strategy officer at Armada Health Care, discusses the impact of the Affordable Care Act on specialty pharmacy industry trends.

Smoking may be especially harmful to patients with irritable bowel disease.

Potential for widespread chaos and eventual collapse of hardest-hit nations without ramped-up international response.

Researchers in Japan are beginning to construct patient-centered counseling techniques for breast cancer by evaluating patient preference.

Respiratory illness now confirmed in 27 states, with significant growth expected in coming weeks.

One major challenge in breast cancer is determining which treatment will be most effective for an individual patient's tumor. With a genetic panel, the TAXSig system may help change that.

Model used to predict eventual size of Ebola outbreak outpaced by scale of current epidemic.

Protein found to play vital role in development of disease.

Camber Pharmaceuticals presents Econdisc Contracting Solutions with Customer of the Year award at the 2014 NACDS Total Store Show.

Efforts to contain the virus increase as death toll continues to rise.

Researchers find 23 new prostate cancer risk sites on the genome.

Paper also offers insight from specific case studies into the ACO-PAC Engagement Spectrum.

Much higher rate of patients in real world discontinuing high priced treatment than during clinical studies.

Disease modifying therapy maintains effects of interferon in the body for a longer duration.

Study finds tolerance varies between individuals determined by their genes.

The severe respiratory virus that is hospitalizing children across the United States has now been confirmed in 17 states.

Michael Nameth, RPh, MBA, chief executive officer of Aureus Health Services, discusses information people entering the field of specialty pharmacy need to know.

Thousands of US military personnel will deploy to West Africa.

Using a less market-oriented payment scheme could reduce high hospital administrative costs.

Baldness on front and crown of head linked to increased chance of developing aggressive prostate cancer.

The FDA has granted approval for the use of hemophilia B treatment Rixubis in pediatric patients.

The respiratory virus that hospitalized hundreds of children in the Midwest and the South has now reached the Northeast.

Researchers found a single receptor that appears to aggravate RA symptoms.